Atlas Genetics Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Atlas Genetics Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7447
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposable cartridge system, which is designed for POC testing services to provide accurate solution to screening for the presence of STIs and HAIs. The company’s products and solutions are used in the diagnosis of sexually transmitted infections, neonatal sepsis, and hospital acquired infection. It serves clinicians and other healthcare professionals. The company operates in the US and the UK. Atlas Genetics is headquartered in Trowbridge, the UK.

Atlas Genetics Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Atlas Genetics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Atlas Genetics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Atlas Genetics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Atlas Genetics Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Atlas Genetics Raises USD35 Million in Series D Financing 10
Atlas Genetics Raises USD20 Million in Series C Financing 12
Partnerships 14
Atlas Genetics Enters into Agreement with Pharma Company 14
Atlas Genetics Ltd – Key Competitors 15
Atlas Genetics Ltd – Key Employees 16
Atlas Genetics Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Jan 05, 2018: Life Sciences Pioneer Stanley Lapidus Joins Atlas Genetics Board of Directors 18
Dec 12, 2017: Atlas Genetics Expands Executive Team, Appointing Marc Jones as Chief Operating Officer and Chief Financial Officer 19
Oct 03, 2017: Atlas Genetics Appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer; Founding CEO Dr John Clarkson Steps Up to Executive Chairman 20
Oct 03, 2017: Atlas Genetics Appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer; Founding CEO Dr John Clarkson Steps Up to Executive Chairman 21
Legal and Regulatory 22
Oct 08, 2018: Atlas Genetics announces company rebranding, changes name to Binx Health 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Atlas Genetics Ltd, Medical Equipment, Key Facts 2
Atlas Genetics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Atlas Genetics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Atlas Genetics Ltd, Deals By Market, 2012 to YTD 2018 8
Atlas Genetics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Atlas Genetics Raises USD35 Million in Series D Financing 10
Atlas Genetics Raises USD20 Million in Series C Financing 12
Atlas Genetics Enters into Agreement with Pharma Company 14
Atlas Genetics Ltd, Key Competitors 15
Atlas Genetics Ltd, Key Employees 16
Atlas Genetics Ltd, Other Locations 17

List of Figures
Atlas Genetics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Atlas Genetics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Atlas Genetics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Atlas Genetics Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IDG Communications Inc:企業の戦略的SWOT分析
    IDG Communications Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Nexeon MedSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes devices and therapies for the treatment of cardiovascular diseases. The company’s products include embolic protection systems, local drug and biologic delivery systems, nanotechnology-based devices, a …
  • Alliqua BioMedical Inc (ALQA):企業の財務・戦略的SWOT分析
    Summary Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc, is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s products comprise ultrasound healing therapy, human biologics, antimicrobial protecti …
  • Lidco Group Plc (LID):企業の財務・戦略的SWOT分析
    Summary Lidco Group Plc (LiDCO) is a medical device company that supplies hemodynamic monitoring equipment. The company offers products such as LiDCOrapid, LiDCOunity, LiDCOplus, LiDCOview and LiDCOaccessories . Its LiDCOplus is a computer-based platform monitor, which is used in the intensive care …
  • Meera Industries Ltd (540519):企業の財務・戦略的SWOT分析
    Meera Industries Ltd (540519) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Axelar AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Axelar AB (Axelar) is a drug development company that develops various novel anti-cancer treatments. The company lead drug candidateAXL1717 is used for the treatmentof non-small cell lung cancer. It also offers treatments for disease such as glioblastoma, sarcoma, malignant melanoma and mult …
  • Weifang Changan Steel Tower Stock Co Ltd:企業の戦略的SWOT分析
    Weifang Changan Steel Tower Stock Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Tamir Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Tamir Biotechnology Inc (Tamir Biotechnology), formerly Alfacell Corp is a clinical stage antiviral therapeutics company that discovers and develops prophylactic and therapeutic drugs for the treatment of viruses and other pathological conditions. The company’s targets include human papillom …
  • Safety-Kleen, Inc.:企業の戦略・SWOT・財務分析
    Safety-Kleen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Safety-Kleen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Revolution Lighting Technologies Inc (RVLT):企業の財務・戦略的SWOT分析
    Revolution Lighting Technologies Inc (RVLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Big 5 Sporting Goods Corporation:企業の戦略・SWOT・財務情報
    Big 5 Sporting Goods Corporation - Strategy, SWOT and Corporate Finance Report Summary Big 5 Sporting Goods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Blue Nile, Inc.:企業の戦略・SWOT・財務情報
    Blue Nile, Inc. - Strategy, SWOT and Corporate Finance Report Summary Blue Nile, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Diamond Offshore Drilling Inc (DO):石油・ガス:M&Aディール及び事業提携情報
    Summary Diamond Offshore Drilling Inc (Diamond Offshore) is an offshore oil and gas drilling company, which provides contract drilling services to the energy industry. It operates through a fleet of offshore drilling rigs comprising semisubmersibles, jack-ups, and dynamically positioned drillships. …
  • TAT Technologies, Ltd.:企業の戦略・SWOT・財務情報
    TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Southern Co (SO):企業の財務・戦略的SWOT分析
    Southern Co (SO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Magellan Midstream Partners LP (MMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Magellan Midstream Partners LP (Magellan Midstream) is a midstream energy company. It transports, stores, and distributes refined petroleum products and crude oil. The company handles various petroleum products such as gasoline, diesel fuel, and crude oil. Magellan Midstream owns and operate …
  • Bta Bank Jsc:企業の戦略・SWOT・財務分析
    Bta Bank Jsc - Strategy, SWOT and Corporate Finance Report Summary Bta Bank Jsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • OncoSec Medical Inc (ONCS):医療機器:M&Aディール及び事業提携情報
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Natus Medical Incorporated (BABY):医療機器:M&Aディール及び事業提携情報
    Summary Natus Medical Incorporated (Natus) is a provider of newborn and neurology healthcare products. It offers wide range of products for the screening, diagnosis, detection, treatment, monitoring and tracking of ailments in newborn. Natus offers products for diagnostic hearing assessment in child …
  • Erytech Pharma SA (ERYP):医療機器:M&Aディール及び事業提携情報
    Summary Erytech Pharma SA (Erytech) is a clinical-stage biopharmaceutical company that provides development of therapies for rare forms of cancer and orphan diseases. The company develops pipeline of product candidates through its proprietary ERYCAPS platform. It offers product candidates which are …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆